Phenylephrine drops - Paragon Bioteck

Drug Profile

Phenylephrine drops - Paragon Bioteck

Alternative Names: Phenylephrine hydrochloride - Paragon Bioteck; R-phenylephrine hydrochloride

Latest Information Update: 27 Nov 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Paragon Bioteck
  • Developer Bausch & Lomb; Paragon Bioteck
  • Class Antihypotensives; Decongestants; Ethanolamines; Gene therapies; Mydriatics; Phenethylamines; Skin disorder therapies; Small molecules; Urologics
  • Mechanism of Action Alpha 1 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Miosis

Most Recent Events

  • 21 Nov 2016 USPTO hands out ruling affirming claims made by Paragon Bioteck in regards to the patent for its phenylephrine hydrochloride formulation
  • 01 Apr 2014 Launched for Miosis (prevention) in USA (Ophthalmic)
  • 05 Aug 2013 Bausch & Lomb has been acquired by Valeant Pharmaceuticals International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top